CliffBio
small molecule

DAYTRANA

METHYLPHENIDATE

Loss of exclusivity—loss of exclusivity
CompanyNoven Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameDAYTRANA
Active ingredientMETHYLPHENIDATE
Strength30MG/9HR (3.3MG/HR)
Dosage formFILM, EXTENDED RELEASE
RouteTRANSDERMAL
ModalitySmall molecule
FDA approvalApril 2006
Marketing statusRX

More from Noven Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.